Contrariwise, silencing of ANXA3 inhibited the expression of N-cadherin and vimentin in pancreatic cancer, while elevating the expression of E-cadherin (Wan et al., 2020). The gene discussed is ANXA3; the disease is familial pancreatic carcinoma.